Playing the Stock Market with Intercytex Shares

Dr. Rassman

I understand you are a doctor, not a financial advisor, but I thought this question was worth mentioning anyway. Currently Intercytex stock is trading around 52 British pounds per share, giving the company a value of about 42 million British pounds. This means that the company is valued at around $83 million. Lets be serious, the success of the cloning procedure is worth way more than that. Lets say there is a 1 in 5 chance of success along with FDA approval within 10 years, the company could be worth a couple billion I’d say. So I would think the stock is a decent bet, at least for those willing to speculate. What do you think?

You are correct in stating that I am a doctor, not a financial adviser. Risks are a matter of timing and intelligent selection. If I knew what to do with discounting the long delays in a financial sense, then it might be worth the gamble. In other words, your best bet is to ask a financial adviser.